Bioptik Technology Incorporation (TPEX:4161)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
26.55
-0.15 (-0.56%)
Jan 22, 2026, 1:30 PM CST
-4.45%
Market Cap1.60B
Revenue (ttm)829.18M
Net Income (ttm)73.58M
Shares Out59.81M
EPS (ttm)1.25
PE Ratio21.33
Forward PEn/a
Dividend0.27 (1.00%)
Ex-Dividend DateAug 20, 2025
Volume130,945
Average Volume155,706
Open26.60
Previous Close26.70
Day's Range26.30 - 26.90
52-Week Range23.72 - 31.59
Beta0.28
RSI64.81
Earnings DateMar 6, 2026

About TPEX:4161

Bioptik Technology Incorporation engages in the manufacturing, wholesale, and retail of biotechnology and medical equipment in Taiwan and internationally. It offers blood glucose, cholesterol, uric acid, hemoglobin and acid multi-function monitoring systems under the EasyMate, EasySure, and EasyTouch brand name, as well as PeTouch Glucose Monitoring System for Dogs and Cats. The company also provides dietary supplements, such as capsules, gel capsules, tablets, solutions, powder sachet, jelly, and gummy; cosmetic products, including sunscreen, ... [Read more]

Sector Healthcare
Founded 1999
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4161
Full Company Profile

Financial Performance

In 2024, TPEX:4161's revenue was 865.34 million, an increase of 4.45% compared to the previous year's 828.50 million. Earnings were 93.57 million, an increase of 9.17%.

Financial Statements